Low-dose inhaled nitric oxide for neonates with pulmonary hypertension

Journal of Paediatrics and Child Health

Volumn 32, Issue 5, 1996, Pages 419-423

  Tang, S F ^a   Miller, O I ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Inhaled nitric oxide; Meconium aspiration syndrome; Neonates; Persistent pulmonary hypertension of the newborn

Indexed keywords

NITRIC OXIDE;

ARTICLE; CLINICAL ARTICLE; CRITICAL ILLNESS; HUMAN; HYPOXEMIA; INHALATIONAL DRUG ADMINISTRATION; MORBIDITY; MORTALITY; NEWBORN; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASODILATATION;

EID: 0029857139     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1996.tb00942.x     Document Type: Article

References (26)

1. Abman SH, Chatfield BA, Rodman DM, Hall SL, McMurty IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am. J. Physiol. 1990; 259: H1921-7.
2. Cornfield DN, Chatfield BA, McQueston JA, McMurty IF, Abman SH. Effects of birth-related stimuli on L-arginine dependent pulmonary vasodilation in the ovine fetus. Am. J. Physiol. 1992; 262: H1474-81.
3. Fineman JR, Chang R, Soifer SJ. EDRF inhibition augments pulmonary hypertension in intact newborn lambs. Am. J. Physiol. 1992; 262: H1365-71.
4. Frostell C, Fratacci M, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038-47.
5. Kinsella JP, McQueston JA, Rosenberg AA, Abman SH. Haemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation. Am. J. Physiol. 1992; 263: H875-80.
6. Roberts JD, Chen TY, Kawai N et al. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn. Circ. Res. 1993; 72: 246-54.
7. Roberts JD, Polander DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 818-19.
8. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low dose inhalational nitric oxide therapy in persistent pulmonary of the newborn. Lancet 1992; 340: 819-20.
9. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Guidelines for the safe administration of inhaled nitric oxide. Arch. Dis. Child. 1994; 70: F47-9.
10. Dworetz AR, Moya FR, Sabo B, Gladstone I, Gross I. Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation. Pediatrics 1989; 84: 1-6.
11. Drummond WH, Gregory G, Heymann MA et al. The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J. Pediatr. 1981; 98: 603-11.
12. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide can cause a selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991; 338: 1173-4.
13. Zapol WM, Hurford WE. Inhaled nitric oxide in the adult respiratory distress syndrome. New Horizons 1993; 1: 638-53.
14. Rossaint R, Falke KJ, Lopez F et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 1993; 328: 399-405.
15. Finer NN, Etches PC, Kamstra B et al. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose response. J. Pediatr. 1994; 124: 302-8.
16. Miller OI, Tang SF, Keech A, Celermajer DS. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 1995; 346: 51-2.
17. Moses D, Holm BA, Spitale P, Liu M, Enhorning G. Inhibition of pulmonary surfactant function by meconium. Am. J. Obstet. Gynecol. 1991; 164: 477-81.
18. James DK, Chiswick ML, Harkes A, Williams M, Hallworth J. Non-specificity of surfactant deficiency in neonatal respiratory disorders. BMJ 1984; 288: 1635-8.
19. Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 1991; 87: 101-7.
20. Khammash H, Perlman M, Wojtulewicz J, Dunn M. Surfactant therapy in full-term neonates with severe respiratory failure. Pediatrics 1993; 92: 135-9.
21. Wiswell TE, Davis JM, Merritt TA. Surfactant therapy and high frequency jet ventilation in the management of a piglet model of meconium aspiration syndrome. Pediatr. Res. 1993; 33: 350A.
22. Kinsella JP, Neish SR, Dunbar Ivy D, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J. Pediatr. 1993; 123: 103-8.
23. Davis JM, Richter SE, Kendig JW, Notter RH. High-frequency jet ventilation and surfactant treatment of newborns with severe respiratory failure. Pediatr. Pulmonol. 1992; 13: 108-12.
24. Center for Disease Control. Recommendations for occupational safety and health standard. MMWR 1988; 37 (Suppl. 7): 1-29.
25. Högman M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet 1993; 341: 1664-5.
26. Lönnqvist PA, Winberg P, Lundell B, Selldén H, Olsson GL. Inhaled nitric oxide in neonates and children with pulmonary hypertension. Acta Paediatr. 1994; 83: 1132-6.